FDA Compliance Expectations Are Changing. Is Your Facility Prepared?

Get In Touch with a Regulatory Expert: https://www.registrarcorp.com/contact... Follow us on social media:   / registrar-corp     / registrarcorp   X / https://x.com/registrarcorp For pharmaceutical manufacturers, FDA compliance challenges often become visible only after they begin disrupting operations, delaying product commercialization, increasing regulatory exposure, or creating unexpected financial obligations. Inaccurate establishment registrations, missed reporting deadlines, or gaps in understanding GDUFA and OMUFA requirements can lead to avoidable compliance risks, facility fee complications, import delays, heightened FDA scrutiny, and, in some cases, product detentions. As regulatory expectations continue to evolve, maintaining a proactive and well-structured compliance strategy is essential for protecting market access and supporting uninterrupted business operations. In this practical webinar, our regulatory experts provide an overview of key FDA regulatory requirements related to registration, reporting, user fee programs, and emerging enforcement trends affecting pharmaceutical manufacturers. Attendees will gain insight into current obligations, submission expectations, common compliance gaps, and recent detention patterns observed across the industry. Topics covered include establishment registration and product listing requirements, CARES Act amount reporting obligations, GDUFA self-identification and facility user fee requirements, OMUFA facility fee considerations, submission timelines, recordkeeping and documentation expectations, and common FDA detention scenarios along with recent enforcement trends observed this year. The session concludes with a live Q&A, giving attendees the opportunity to discuss specific compliance questions directly with our regulatory experts. Watch this webinar to strengthen your FDA compliance strategy, reduce regulatory risk, and better prepare your organization for evolving enforcement expectations.